Oncolytics Biotech, Inc. (ONCY) trading halted with news pending
- Market Wrap: EC Boosts Euro-Area GDP Outlook; Tesla Ramps on Upgrade; Crude Closes Back Over $60/bbl
- Microsoft (MSFT) Said to Consider Bid for salesforce.com (CRM)
- After-Hours Stock Movers 05/05: (BRDR) (MGI) (HLF) Higher; (ZU) (NDLS) (ANAD) Lower (more...)
- Comcast (CMCSA) Plans to Refocus on Customer Service Improvement; Create 5,500 Jobs
- Herbalife (HLF) Tops Q1 EPS by 28c; Boosts FY15 EPS Outlook
Oncolytics Biotech, Inc. (NASDAQ: ONCY) trading halted with news pending.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oncolytics Biotech (ONCY) Granted Orphan Drug Designation for Treatment of Gastric Cancer
- Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Status from the EMA for Pancreatic Cancer
- CFO Noto Taking Control of Twitter (TWTR) Marketing Department - the Verge
Create E-mail Alert Related CategoriesTrading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!